CME Group Inc. officer John C. Marchese filed a Form 144 notice of proposed sale of 655 shares of CME Group common stock, with an approximate sale date of November 18, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services.

Key Highlights

  • Filer and role: John C. Marchese is identified as an Officer of CME Group Inc.
  • Shares proposed for sale: 655 shares of CME Group common stock, with an aggregate market value of $203,541.25.
  • Approximate sale date: November 18, 2026, to be executed on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.
  • Source of shares: The securities were acquired as restricted stock from the issuer, in four separate lots on September 15, 2025 (166 shares, 178 shares, and 175 shares) and September 16, 2025 (136 shares).
  • Shares outstanding: The filing states 357,930,746 shares of CME Group common stock outstanding.
  • Prior sales: The filing reports nothing to report for securities sold during the past three months.

John C. Marchese's Proposed Rule 144 Sale of CME Group Restricted Stock

According to the Form 144 filed with the U.S. Securities and Exchange Commission, John C. Marchese, an officer of CME Group Inc. (NASDAQ:CME), has provided notice of a proposed sale of 655 shares of the company's common stock. The aggregate market value of the shares proposed for sale is listed as $203,541.25. The broker named in the filing is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

The filing discloses that the 655 shares to be sold were acquired as restricted stock directly from the issuer. The acquisition is broken into four lots: 166 shares on September 15, 2025; 178 shares on September 15, 2025; 175 shares on September 15, 2025; and 136 shares on September 16, 2025. The nature of payment for all lots is listed as "Not Applicable," and none are identified as gifts, according to the filing.

The notice states that Marchese "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed," as required by the Form 144 attestation. No remarks were added, and the filing reports no sales of CME Group securities by Marchese during the three months prior to this notice. CME Group Inc. is headquartered at 20 South Wacker Drive, Chicago, Illinois, 60606.

What Was Disclosed

A Form 144 notice was filed on November 18, 2026, by CME Group officer John C. Marchese, disclosing a proposed sale of 655 shares of common stock with an aggregate market value of $203,541.25, acquired as restricted stock from the issuer in September 2025.